Skip to main content

Infection Secondary to Surgical Procedure

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Altacor
AltacorUK - Berkshire
1 program
1
ALT005 Ophthalmic Prep SolutionPhase 31 trial
Active Trials
NCT01531699Completed54Est. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AltacorALT005 Ophthalmic Prep Solution

Clinical Trials (1)

Total enrollment: 54 patients across 1 trials

NCT01531699AltacorALT005 Ophthalmic Prep Solution

Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution in Healthy Volunteers

Start: Feb 2012Est. completion: Dec 201254 patients
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.